Minesh Khatri1, Yeseon P Moon2, Nikolaos Scarmeas3, Yian Gu4, Hannah Gardener5, Ken Cheung6, Clinton B Wright5, Ralph L Sacco5, Thomas L Nickolas7, Mitchell S V Elkind8. 1. Division of Nephrology, Departments of Medicine and mk2642@columbia.edu. 2. Neurology, College of Physicians and Surgeons. 3. Neurology, College of Physicians and Surgeons, Gertrude H. Sergievsky Center, Taub Institute for Research in Alzheimer's Disease and the Aging Brain, and Department of Social Medicine, Psychiatry, and Neurology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; and. 4. Taub Institute for Research in Alzheimer's Disease and the Aging Brain, and. 5. Evelyn F. McKnight Brain Institute, Department of Neurology, University of Miami, Miami, Florida. 6. Neurology, College of Physicians and Surgeons, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York; 7. Division of Nephrology, Departments of Medicine and. 8. Neurology, College of Physicians and Surgeons, Gertrude H. Sergievsky Center, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York;
Abstract
BACKGROUND AND OBJECTIVES: Various dietary strategies have been investigated to slow kidney function decline. However, it is unknown whether a Mediterranean diet, which has been associated with improved cardiovascular risk, is associated with change in kidney function. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study used the Northern Manhattan Study, a prospective, multiethnic, observational cohort of participants who were stroke free at baseline. Data were collected between 1993 and 2008. Serum creatinine measurements were taken a mean 6.9 years apart. A baseline dietary questionnaire was extrapolated into a previously used 9-point scoring system (MeDi). The primary outcome was incident eGFR<60 ml/min per 1.73 m(2)using the Modification of Diet in Renal Disease formula. A secondary outcome was the upper quartile of annualized eGFR decline (≥ 2.5 ml/min per 1.73 m(2) per year). Conditional logistic regression models adjusted for demographics and baseline vascular risk factors. RESULTS: Mean baseline age was 64 years, with 59% women and 65% Hispanics (N=900); mean baseline eGFR was 83.1 ml/min per 1.73 m(2). Incident eGFR<60 ml/min per 1.73 m(2) developed in 14% . In adjusted models, every 1-point increase in the MeDi score, indicating increasing adherence to a Mediterranean diet, was associated with decreased odds of incident eGFR<60 ml/min per 1.73 m(2) (odds ratio, 0.83; 95% confidence interval, 0.71 to 0.96) and decreased odds of being in the upper quartile of eGFR decline (odds ratio, 0.88; 95% confidence interval, 0.79 to 0.98). CONCLUSIONS: A Mediterranean diet was associated with a reduced incidence of eGFR<60 ml/min per 1.73 m(2) and upper quartile of eGFR decline in a multiethnic cohort.
BACKGROUND AND OBJECTIVES: Various dietary strategies have been investigated to slow kidney function decline. However, it is unknown whether a Mediterranean diet, which has been associated with improved cardiovascular risk, is associated with change in kidney function. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study used the Northern Manhattan Study, a prospective, multiethnic, observational cohort of participants who were stroke free at baseline. Data were collected between 1993 and 2008. Serum creatinine measurements were taken a mean 6.9 years apart. A baseline dietary questionnaire was extrapolated into a previously used 9-point scoring system (MeDi). The primary outcome was incident eGFR<60 ml/min per 1.73 m(2)using the Modification of Diet in Renal Disease formula. A secondary outcome was the upper quartile of annualized eGFR decline (≥ 2.5 ml/min per 1.73 m(2) per year). Conditional logistic regression models adjusted for demographics and baseline vascular risk factors. RESULTS: Mean baseline age was 64 years, with 59% women and 65% Hispanics (N=900); mean baseline eGFR was 83.1 ml/min per 1.73 m(2). Incident eGFR<60 ml/min per 1.73 m(2) developed in 14% . In adjusted models, every 1-point increase in the MeDi score, indicating increasing adherence to a Mediterranean diet, was associated with decreased odds of incident eGFR<60 ml/min per 1.73 m(2) (odds ratio, 0.83; 95% confidence interval, 0.71 to 0.96) and decreased odds of being in the upper quartile of eGFR decline (odds ratio, 0.88; 95% confidence interval, 0.79 to 0.98). CONCLUSIONS: A Mediterranean diet was associated with a reduced incidence of eGFR<60 ml/min per 1.73 m(2) and upper quartile of eGFR decline in a multiethnic cohort.
Authors: Ramon Estruch; Miguel Angel Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Valentina Ruiz-Gutiérrez; María Isabel Covas; Miguel Fiol; Enrique Gómez-Gracia; Mari Carmen López-Sabater; Ernest Vinyoles; Fernando Arós; Manuel Conde; Carlos Lahoz; José Lapetra; Guillermo Sáez; Emilio Ros Journal: Ann Intern Med Date: 2006-07-04 Impact factor: 25.391
Authors: F Fuentes; J López-Miranda; E Sánchez; F Sánchez; J Paez; E Paz-Rojas; C Marín; P Gómez; J Jimenez-Perepérez; J M Ordovás; F Pérez-Jiménez Journal: Ann Intern Med Date: 2001-06-19 Impact factor: 25.391
Authors: Ram B Singh; Gal Dubnov; Mohammad A Niaz; Saraswati Ghosh; Reema Singh; Shanti S Rastogi; Orly Manor; Daniel Pella; Elliot M Berry Journal: Lancet Date: 2002-11-09 Impact factor: 79.321
Authors: Xiaoyan Huang; José Juan Jiménez-Moleón; Bengt Lindholm; Tommy Cederholm; Johan Arnlöv; Ulf Risérus; Per Sjögren; Juan Jesús Carrero Journal: Clin J Am Soc Nephrol Date: 2013-06-06 Impact factor: 8.237
Authors: Javier S Perona; Julio Cañizares; Emilio Montero; José M Sánchez-Domínguez; Angel Catalá; Valentina Ruiz-Gutiérrez Journal: Clin Nutr Date: 2004-10 Impact factor: 7.324
Authors: Tazeen H Jafar; Paul C Stark; Christopher H Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert Toto; Andrew S Levey Journal: Ann Intern Med Date: 2003-08-19 Impact factor: 25.391
Authors: Eric L Knight; Meir J Stampfer; Susan E Hankinson; Donna Spiegelman; Gary C Curhan Journal: Ann Intern Med Date: 2003-03-18 Impact factor: 25.391
Authors: Katrina E Bach; Jaimon T Kelly; Suetonia C Palmer; Saman Khalesi; Giovanni F M Strippoli; Katrina L Campbell Journal: Clin J Am Soc Nephrol Date: 2019-09-24 Impact factor: 8.237
Authors: Hyunju Kim; Laura E Caulfield; Vanessa Garcia-Larsen; Lyn M Steffen; Morgan E Grams; Josef Coresh; Casey M Rebholz Journal: Clin J Am Soc Nephrol Date: 2019-04-25 Impact factor: 8.237
Authors: Tanushree Banerjee; Deidra C Crews; Donald E Wesson; Sai Dharmarajan; Rajiv Saran; Nilka Ríos Burrows; Sharon Saydah; Neil R Powe Journal: Am J Kidney Dis Date: 2017-02-16 Impact factor: 8.860
Authors: Jonathan J Suarez; Tamara Isakova; Cheryl A M Anderson; L Ebony Boulware; Myles Wolf; Julia J Scialla Journal: Am J Prev Med Date: 2015-12 Impact factor: 5.043
Authors: Jaimon T Kelly; Suetonia C Palmer; Shu Ning Wai; Marinella Ruospo; Juan-Jesus Carrero; Katrina L Campbell; Giovanni F M Strippoli Journal: Clin J Am Soc Nephrol Date: 2016-12-08 Impact factor: 8.237